New eye drop shows promise for dry eye relief in phase 3 trial
NCT ID NCT06424444
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This study tested an eye drop called reproxalap in 421 adults with dry eye disease. Participants used the drops or a placebo for up to 6 weeks. The main goal was to see if the drops reduce eye discomfort better than placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Core, Inc.
Shelby, North Carolina, 28150, United States
Conditions
Explore the condition pages connected to this study.